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Background:  Diastolic pressure difference of 7 mm Hg has been shown to be very good discriminator of the presence of pre-capillary 
component in patients with WHO group II PH. Presence of combined pre and post capillary pulmonary hypertension (CPC-PH) portends 
highest risk of mortality in patients with WHO group II PH. Echo indicators of CPC-PH in systolic heart failure (HF) are unknown.
methods:  We performed a retrospective chart review of 109 patients with systolic HF who were referred to our center for heart failure 
advanced therapies. Laboratory and hemodynamic data (acquired during right heart catheterization) were obtained within 5 ±7 days 
(median 4 days) of the echocardiogram. Patients were grouped based on their Diastolic Pressure Gradient (DPD) of 7< or ≥ 7, and 
excluded those with missing data, therefore the final study population comprised of 63 patients. ROC curves were constructed to determine 
optimal cut-off values.
results:  In the final study population of 63 patients, the mean age was 56 ±13; 46 (73%) were male, 32 (51%) Caucasian and 38 (60%) 
had ischemic cardiomyopathy. Mean LVEF and LVEDD were 18.5±7.2 and 6.6±0.9 respectively. A total of 12 (19%) patients had DPD 
≥7, their mean PCWP was 21 ± 7 mmHg, and in the DPD <7 group mean PCWP was 25 ± 6 mm Hg. We studied a total of 22 echo 
parameters (2D, Doppler and tissue Doppler) for the right side of the heart and 15 left sided parameters. Right sided echo parameters that 
had good discrimination for DPD ≥7, were Right Ventricular (RV) diameter at the base with a cut-off of 4.75 cm, AUC=0.69 (CI= 0.52-0.87) 
p-value=0.04(sensitivity 75%; specificity 60%). RV End Systolic (RVES) area with a cut-off of 24 cm2 had an AUC=0.71 (CI= 0.54-0.88), 
p-value= 0.02 (sensitivity 80% and specificity 54%). Echo derived PA pressures, TAPSE, echo derived PVR, acceleration time, and RVOT 
VTI notching were not significant. Among the left sided parameters LA volume index had good accuracy (p-value= 0.03) in distinguishing 
patients with RV diameter at the base >4.75cm and RVES areas >24 cm2.
conclusion:  We have identified RV basal dimension, RVES area and LA volume index as potential echo discriminators of the presence of 
CPC-PH in a population of systolic heart failure with WHO group II PH.
